{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1097","meta":{"versionId":"22","lastUpdated":"2016-03-31T01:00:12.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2016-03-31"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1097","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1097"}],"version":"20160331","name":"MastCellStabilizer","title":"Mast Cell Stabilizer","status":"active","experimental":false,"date":"2016-03-31T01:00:12-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Under Development),(Data Element Scope: Under Development),(Inclusion Criteria: Under Development),(Exclusion Criteria: Under Development)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"831246","display":"Cromolyn Sodium 10 MG/ML Inhalant Solution"},{"code":"831257","display":"Cromolyn Sodium 0.8 MG/ACTUAT Inhalant Powder"},{"code":"885241","display":"Cromolyn Sodium 5 MG/ACTUAT Inhalant Powder"}]}]},"expansion":{"identifier":"urn:uuid:4b7dc3c8-4549-457a-b1ac-9ee7e5883f5b","timestamp":"2023-12-11T02:29:52-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"831246","display":"cromolyn sodium 10 MG/ML Inhalation Solution"}]}}